價格 | ¥987 | ¥1490 | ¥2390 |
包裝 | 1mg | 2mg | 5mg |
最小起訂量 | 1mg |
發(fā)貨地 | 上海 |
更新日期 | 2025-02-28 |
中文名稱:化合物 GSK199 | 英文名稱:GSK199 |
CAS:1549811-53-1 | 品牌: TargetMol |
產(chǎn)地: 美國 | 保存條件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
純度規(guī)格: 99.44% | 產(chǎn)品類別: 抑制劑 |
貨號: T8861 |
名稱 | GSK199 |
描述 | GSK199 is a selective PAD4 inhibitor(IC50 of 200 nM in the absence of calcium). |
體內(nèi)活性 | GSK199, in the murine collagen-induced arthritis model of rheumatoid arthritis. Mice were dosed daily from the time of collagen immunization with GSK199. Efficacy was assessed against a wide range of end-points, including clinical disease scores, joint histology and immunohistochemistry, serum and joint citrulline levels and quantification of synovial autoantibodies using a proteomic array containing joint peptides. Administration of GSK199 at 30 mg/kg led to significant effects on arthritis, assessed both by global clinical disease activity and by histological analyses of synovial inflammation, pannus formation and damage to cartilage and bone. In addition, significant decreases in complement C3 deposition in both synovium and cartilage were observed robustly with GSK199 at 10 mg/kg. Neither the total levels of citrulline measurable in joint and serum, nor levels of circulating collagen antibodies, were affected significantly by treatment with GSK199 at any dose level. In contrast, a subset of serum antibodies reactive against citrullinated and non-citrullinated joint peptides were reduced with GSK199 treatment. |
存儲條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度 | DMSO : 11 mg/mL (23.45 mM) |
關(guān)鍵字 | GSK 199 | Inhibitor | Peptidylarginine Deiminase | GSK-199 | GSK199 | Protein Arginine Deiminase | inhibit |
相關(guān)產(chǎn)品 | BMS-P5 | BMS-P5 free base | Bongkrekic acid | Acefylline | GSK484 hydrochloride | GSK121 | N-[1-(Aminocarbonyl)-4-[(2-chloro-1-iminoethyl)amino]butyl]benzamide | Cl-amidine hydrochloride |
相關(guān)庫 | 抑制劑庫 | 經(jīng)典已知活性庫 | 已知活性化合物庫 | NO PAINS 化合物庫 | 表觀遺傳庫 |
成立日期 | 2013-04-18 (12年) | 注冊資本 | 566.265100萬人民幣 |
員工人數(shù) | 100-500人 | 年營業(yè)額 | ¥ 1億以上 |
主營行業(yè) | 天然產(chǎn)物,生化試劑,分子生物學,分子砌塊,生物技術(shù)服務 | 經(jīng)營模式 | 貿(mào)易,工廠,試劑,定制,服務 |
產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
詢價 |
VIP3年
|
陜西締都新材料有限公司
|
2025-03-06 | |
¥198 |
VIP12年
|
上海陶術(shù)生物科技有限公司
|
2025-03-12 | |
詢價 |
VIP1年
|
青島愷潤生物醫(yī)藥科技有限公司
|
2025-02-07 | |
詢價 |
星基醫(yī)藥(上海)有限公司
|
2025-03-12 |